CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | LEONARD JOHN M President and CEO | Option exercise | +60,000 | $22.78 | $1.4M | 598,814 |
| 2021-02-01 | LEONARD JOHN M President and CEO | Sale | −11,100 | $63.30 | $703K | 587,714 |
| 2021-02-01 | LEONARD JOHN M President and CEO | Sale | −16,640 | $64.10 | $1.1M | 571,074 |
| 2021-02-01 | LEONARD JOHN M President and CEO | Sale | −5,475 | $65.04 | $356K | 565,599 |
| 2021-02-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −100,000 | 125,234 | ||
| 2021-02-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −10,000 | 85,000 | ||
| 2021-02-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −30,000 | 27,500 | ||
| 2021-02-01 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −60,000 | 160,000 | ||
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise | +66,000 | $6.83 | $451K | 120,068 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −10,476 | $63.31 | $663K | 109,592 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −15,594 | $64.11 | $1000K | 93,998 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −5,312 | $65.01 | $345K | 88,686 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise | +33,000 | $13.88 | $458K | 121,686 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −6,617 | $63.34 | $419K | 115,069 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −8,366 | $64.16 | $537K | 106,703 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −2,827 | $65.05 | $184K | 103,876 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise | +10,000 | $14.58 | $146K | 113,876 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −2,326 | $63.44 | $148K | 111,550 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −2,386 | $64.18 | $153K | 109,164 |
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Sale | −755 | $65.07 | $49K | 108,409 |
Page 27 of 40 · 783 trades